Dynavax Operating Income from 2010 to 2026

DVAX Stock

USD 15.50 0.01 0.06%

Dynavax Technologies Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about -5 M in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Dynavax Technologies generates from its operations. View All Fundamentals

Operating Income

First Reported

2001-12-31

Previous Quarter

14.4 M

Current Value

21.3 M

Quarterly Volatility

25 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 M, Interest Expense of 4.2 M or Other Operating Expenses of 339.8 M, as well as many indicators such as Price To Sales Ratio of 5.12, Dividend Yield of 0.0 or PTB Ratio of 4.39. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.

Build AI portfolio with Dynavax Stock

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The evolution of Operating Income for Dynavax Technologies provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Dynavax Technologies compares to historical norms and industry peers.

Latest Dynavax Technologies' Operating Income Growth Pattern

Below is the plot of the Operating Income of Dynavax Technologies over the last few years. Operating Income is the amount of profit realized from Dynavax Technologies operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Dynavax Technologies is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Dynavax Technologies' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Dynavax Operating Income Regression Statistics

	Arithmetic Mean	(34,744,977)
	Coefficient Of Variation	(304.36)
	Mean Deviation	70,938,147
	Median	(66,488,000)
	Standard Deviation	105,750,136
	Sample Variance	11183.1T
	Range	436.8M
	R-Value	0.36
	Mean Square Error	10342.5T
	R-Squared	0.13
	Significance	0.15
	Slope	7,636,361
	Total Sum of Squares	178929.5T

Dynavax Operating Income History

	2026	-5 M
	2025	-4.7 M
	2024	-4.1 M
	2023	-37 M
	2022	283.5 M
	2021	134.5 M
	2020	-75.2 M

Other Fundumenentals of Dynavax Technologies

Non Operating Income Net Other

Dynavax Technologies Operating Income component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Total Current Assets	Net Receivables	Good Will	Intangible Assets	Long Term Debt	Short Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.9	-0.43	0.87	0.62	0.87	0.25	0.9	0.55	0.4	1.0	0.79	-0.7	-0.12	0.9	-0.3	0.89	0.8	0.79	0.84	-0.55	0.89	0.93	0.95
Total Stockholder Equity	0.9		-0.2	0.58	0.63	0.97	0.27	0.65	0.19	0.47	0.89	0.58	-0.68	-0.17	0.73	-0.18	0.99	0.66	0.59	0.67	-0.61	0.91	0.96	0.81
Retained Earnings	-0.43	-0.2		-0.6	-0.47	-0.22	0.01	-0.72	-0.4	-0.33	-0.42	-0.41	0.41	-0.09	-0.63	0.7	-0.11	-0.77	-0.71	-0.75	0.04	-0.24	-0.22	-0.5
Total Liab	0.87	0.58	-0.6		0.46	0.55	0.16	0.96	0.81	0.22	0.88	0.84	-0.55	-0.03	0.89	-0.38	0.56	0.77	0.83	0.83	-0.36	0.66	0.68	0.87
Accounts Payable	0.62	0.63	-0.47	0.46		0.75	0.03	0.6	-0.03	0.76	0.57	0.17	-0.77	0.06	0.7	-0.34	0.59	0.64	0.69	0.66	-0.66	0.53	0.69	0.57
Short Term Investments	0.87	0.97	-0.22	0.55	0.75		0.25	0.63	0.09	0.64	0.84	0.45	-0.7	-0.12	0.76	-0.17	0.96	0.66	0.65	0.67	-0.67	0.87	0.97	0.8
Common Stock	0.25	0.27	0.01	0.16	0.03	0.25		0.15	0.16	0.07	0.26	0.21	0.32	-0.18	0.15	0.49	0.26	0.12	0.11	0.05	-0.01	0.26	0.2	0.24
Property Plant Equipment	0.9	0.65	-0.72	0.96	0.6	0.63	0.15		0.71	0.32	0.89	0.79	-0.66	-0.11	0.91	-0.49	0.61	0.87	0.85	0.91	-0.41	0.68	0.72	0.89
Current Deferred Revenue	0.55	0.19	-0.4	0.81	-0.03	0.09	0.16	0.71		-0.36	0.58	0.72	-0.16	-0.11	0.47	-0.24	0.19	0.44	0.4	0.47	-0.01	0.31	0.28	0.52
Net Debt	0.4	0.47	-0.33	0.22	0.76	0.64	0.07	0.32	-0.36		0.35	0.0	-0.48	0.08	0.62	-0.15	0.46	0.49	0.64	0.5	-0.48	0.45	0.54	0.51
Total Current Assets	1.0	0.89	-0.42	0.88	0.57	0.84	0.26	0.89	0.58	0.35		0.82	-0.67	-0.13	0.89	-0.3	0.88	0.79	0.77	0.82	-0.53	0.88	0.91	0.94
Net Receivables	0.79	0.58	-0.41	0.84	0.17	0.45	0.21	0.79	0.72	0.0	0.82		-0.43	-0.13	0.71	-0.26	0.58	0.64	0.62	0.69	-0.19	0.67	0.55	0.77
Good Will	-0.7	-0.68	0.41	-0.55	-0.77	-0.7	0.32	-0.66	-0.16	-0.48	-0.67	-0.43		-0.01	-0.68	0.52	-0.65	-0.66	-0.63	-0.74	0.59	-0.64	-0.72	-0.64
Intangible Assets	-0.12	-0.17	-0.09	-0.03	0.06	-0.12	-0.18	-0.11	-0.11	0.08	-0.13	-0.13	-0.01		0.04	-0.08	-0.18	-0.01	0.26	-0.08	0.0	-0.15	-0.13	-0.16
Long Term Debt	0.9	0.73	-0.63	0.89	0.7	0.76	0.15	0.91	0.47	0.62	0.89	0.71	-0.68	0.04		-0.4	0.7	0.87	0.96	0.9	-0.49	0.78	0.81	0.94
Short Term Debt	-0.3	-0.18	0.7	-0.38	-0.34	-0.17	0.49	-0.49	-0.24	-0.15	-0.3	-0.26	0.52	-0.08	-0.4		-0.12	-0.61	-0.43	-0.57	0.07	-0.2	-0.18	-0.32
Net Tangible Assets	0.89	0.99	-0.11	0.56	0.59	0.96	0.26	0.61	0.19	0.46	0.88	0.58	-0.65	-0.18	0.7	-0.12		0.62	0.56	0.63	-0.61	0.91	0.96	0.8
Capital Surpluse	0.8	0.66	-0.77	0.77	0.64	0.66	0.12	0.87	0.44	0.49	0.79	0.64	-0.66	-0.01	0.87	-0.61	0.62		0.85	0.97	-0.23	0.77	0.68	0.87
Deferred Long Term Liab	0.79	0.59	-0.71	0.83	0.69	0.65	0.11	0.85	0.4	0.64	0.77	0.62	-0.63	0.26	0.96	-0.43	0.56	0.85		0.86	-0.42	0.65	0.68	0.84
Long Term Debt Total	0.84	0.67	-0.75	0.83	0.66	0.67	0.05	0.91	0.47	0.5	0.82	0.69	-0.74	-0.08	0.9	-0.57	0.63	0.97	0.86		-0.28	0.77	0.71	0.9
Short Long Term Debt	-0.55	-0.61	0.04	-0.36	-0.66	-0.67	-0.01	-0.41	-0.01	-0.48	-0.53	-0.19	0.59	0.0	-0.49	0.07	-0.61	-0.23	-0.42	-0.28		-0.34	-0.66	-0.42
Net Invested Capital	0.89	0.91	-0.24	0.66	0.53	0.87	0.26	0.68	0.31	0.45	0.88	0.67	-0.64	-0.15	0.78	-0.2	0.91	0.77	0.65	0.77	-0.34		0.9	0.9
Net Working Capital	0.93	0.96	-0.22	0.68	0.69	0.97	0.2	0.72	0.28	0.54	0.91	0.55	-0.72	-0.13	0.81	-0.18	0.96	0.68	0.68	0.71	-0.66	0.9		0.87
Capital Stock	0.95	0.81	-0.5	0.87	0.57	0.8	0.24	0.89	0.52	0.51	0.94	0.77	-0.64	-0.16	0.94	-0.32	0.8	0.87	0.84	0.9	-0.42	0.9	0.87

Click cells to compare fundamentals

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-4.7 M	-5 M
Non Operating Income Net Other	8.8 M	9.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Dynavax Operating Income from 2010 to 2026

Latest Dynavax Technologies' Operating Income Growth Pattern

Dynavax Operating Income Regression Statistics

Dynavax Operating Income History

Other Fundumenentals of Dynavax Technologies

Dynavax Technologies Operating Income component correlations

About Dynavax Technologies Financial Statements

Also Currently Popular

Additional Tools for Dynavax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY